|
THIRD ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES
A Pharma Congress Conference
March 9 - 11, 2011
|
ONSITE
Wardman Park Hotel
Washington, DC
|
OR |
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months
|
 |
|
|
KEYNOTE SPEAKERS
|
Eric G. Campbell, PhD
Associate Professor of Medicine, Harvard Medical School, Director of Research, Mongan Institute for Health Policy, Boston, MA |
Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former First Assistant US Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC |
Jack Mitchell
Chief of Oversight and Investigations, Special Committee on Aging, United States Senate, Former Director, Commissioner's Office of Special Investigations, US Food and Drug Administration, Washington, DC
|
Mary E. Riordan, Esq.
Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC |
James G. Sheehan, Esq.
New York State Medicaid, Inspector General, Former Associate United States Attorney, US Attorney's Office, Eastern District of Pennsylvania, Albany, NY
|
|
|
|
CO CHAIRS
|
Frank Bigley
Chief Compliance Officer, Novo Nordisk Inc., Princeton, NJ |
William E. Buzzeo, MS
Vice President and General Manager Compliance Solutions Division, Cegedim Relationship Management, Richmond, VA |
Sarah K. Giesting, Esq.
Associate, Epstein Becker & Green, New York, NY
|
Jonathon Kellerman
Principal, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers LLP, Florham Park, NJ |
Karen Lowney
Senior Director, Global Compliance, Cephalon, Frazer, PA |
Rore Middleton, Esq.
Senior Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT
|
Paul J. Silver
Managing Director and Practice Leader, Life Sciences Advisory Services Practice, Huron Consulting Group, LLC, Atlanta, GA |
Heidi Straub
Senior Director, Physician Aggregate Spend Team (PhAST), Eli Lilly and Company, Indianapolis, IN |
Jack T. Tanselle
Director, Navigant Consulting, Inc., Chicago, IL
|
|
|
|
FEATURING SESSIONS ON
|
|
The Basics of Disclosure/Aggregate Spend Technology Solutions
2010 US and Global Transparency Management Industry Survey Findings
Training the New Disclosure/Aggregate Spend Compliance Workforce
Disseminated Data Utilization in Anti-Kickback and False Claims Enforcement
Best Practices in Structure: Project Management and Staffing
Best Practices in Training and Branding
Best Practices in Program Ownership: Compliance, Finance, HR and/or IT
Best Practices in Communicating Transparency Initiatives to Customers
Best Practices in Capturing Correct Information and Ensuring Accuracy
Best Practices: A Comprehensive Approach to Managing your HCP Spend |
|
Managing Change in Transparency Programs: Process, Change Management and Strategic Decisions
Why Most Drug and Device Companies will Comply Prior to the Sunshine Act Deadline
After Sunshine: Preparing to Deal with the Likely Consequences of Public Disclosures
The Role of the Office of Inspector General
The Continuing Role of Congress in Sunshine Act Implementation
State Disclosure Laws Update
How Disclosure is Reshaping State Enforcement Initiatives
Aggregate Spend 2.0: MD Disclosure
Drug Sample Disclosure: the Next Horizon
Complying with Vermont's Drug Sample Requirement
Company Approaches to Aggregate Spend Technology Solutions
Aggregate Spend Technology Solution Provider Roundtable
|
|
|
FEATURED FACULTY
|
Ben Carmel
Aggregate Spend Technology Specialist, Polaris Management Partners, New York, NY |
Mitch Chi
Senior Vice President Sales, Health Market Science, King of Prussia, PA |
Jennifer Colapietro
Partner, Transparency and Aggregate Spend Practice Lead, PricewaterhouseCoopers LLP, Florham Park, NJ
|
Danielle M. Drissel, Esq.
Associate, Hogan Lovells, US, LLP, Washington, DC |
Dan S. Dunham
Vice President, Corporate Compliance, and Chief Compliance Officer, Astellas Pharma US, Inc., Deerfield, IL |
Marc Eigner, MS
Partner, Polaris Management Partners, New York, NY
|
Jennifer Gomez
Associate Director, CRM IT, Shire, Wayne, PA |
Lori Greene, MA
Senior Principal, R-Squared, Director, Commercial Compliance, Stiefel Laboratories, Inc., Atlanta, GA |
Bill Hadad
Consultant - State Reporting Operations, Lilly USA, LLC - Bio-Medicines, Indianapolis, IN
|
Seth H. Lundy, Esq.
Partner and Deputy Chair, FDA and Life Sciences Practice Group, King & Spalding LLP, Washington, DC |
Kim Mills
Senior Vice President, AHM Compliance Solutions, Bridgewater, NJ |
Patrick M. Mooty, Esq.
Senior Director, Ethics and Compliance, Fresenius Medical Care, Waltham, MA
|
Wendy Morgan, Esq.
Chief of Public Protection Division, Vermont Office of the Attorney General, Montpelier, VT |
Kirk Ogrosky, Esq.
Partner, Arnold & Porter, Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice; Former Assistant US Attorney, US Attorney's Office for the Southern District of Florida; Former Assistant Attorney General, Kentucky, Washington, DC |
John Patrick Oroho, Esq.
Executive Vice President, Porzio Pharmaceutical Services, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ
|
Kathleen A. Peterson, Esq.
Partner, Health Care and Life Sciences Practice Group, Epstein Becker & Green, Washington, DC |
John Poulin
Chief Solutions Architect, Life Sciences Advisory Services Practice, Huron Consulting Group, LLC, New York, NY |
Marjorie E. Powell, Esq.
Senior Assistant General Counsel, Pharmaceutical Research and Manufacturers of America, Washington, DC
|
Christina F. Rich, Esq.
Vice President, Business Ethics and Compliance, Cardiac and Vascular Group, Medtronic, Minneapolis, MN |
Luanna Saulino
Associate Director, State Law Reporting, Bayer Healthcare, Wayne, NJ |
Trudy J. Seeley, Esq.
Compliance Manager, State Law Compliance and US Corporate Compliance, sanofi-aventis, Bridgewater, NJ
|
Don Soong
Senior Director, Compliance Solutions Development, Cegedim Dendrite, Bedminster, NJ |
James C. Stansel, Esq.
Partner and Co-head, Global Life Sciences Team, Sidley Austin LLP, Former Acting General Counsel, US Department of Health and Human Services, Washington, DC |
Jon Wilkenfeld, MBA
President, Potomac River Partners, Vienna, VA
|
Ronald L. Wisor, Jr., Esq.
Partner, Hogan Lovells, US, LLP, Washington, DC |
Kim Zahan
Director R&D Financial Compliance, GlaxoSmithKline, King of Prussia, PA
|
|
|
|
|
|
